KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Minority Interest (2023 - 2025)

Edwards Lifesciences (EW) has 3 years of Minority Interest data on record, last reported at $61.2 million in Q2 2025.

  • For Q2 2025, Minority Interest fell 8.93% year-over-year to $61.2 million; the TTM value through Jun 2025 reached $61.2 million, down 8.93%, while the annual FY2024 figure was $64.5 million, 7.06% down from the prior year.
  • Minority Interest reached $61.2 million in Q2 2025 per EW's latest filing, down from $62.9 million in the prior quarter.
  • Across five years, Minority Interest topped out at $84.0 million in Q1 2023 and bottomed at $61.2 million in Q2 2025.
  • Average Minority Interest over 3 years is $68.4 million, with a median of $67.8 million recorded in 2024.
  • The widest YoY moves for Minority Interest: up 5.08% in 2024, down 18.45% in 2024.
  • A 3-year view of Minority Interest shows it stood at $69.4 million in 2023, then fell by 7.06% to $64.5 million in 2024, then dropped by 5.12% to $61.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Minority Interest were $61.2 million in Q2 2025, $62.9 million in Q1 2025, and $64.5 million in Q4 2024.